Maxalt (Rizatriptan Benzoate)

Rizatriptan works by selectively stimulating 5‑HT1B and 5‑HT1D receptors located on cranial blood vessels and trigeminal nerve fibers. This action leads to vasoconstriction of dilated intracranial vessels and blocks the release of inflammatory neuropeptides, interrupting the migraine cascade and reducing pain.

The specific dose of Maxalt is determined by the prescribing healthcare professional based on individual patient factors. Common tablet strengths are 5 mg and 10 mg, but the prescriber decides the appropriate amount, timing, and frequency for each patient.

Rizatriptan is classified as Pregnancy Category B, indicating no evidence of risk in animal studies but a lack of well‑controlled studies in pregnant women. It should be used during pregnancy or lactation only if the potential benefit justifies the potential risk, and after consulting a healthcare provider.

To order Maxalt, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Both Maxalt (rizatriptan) and sumatriptan belong to the triptan class and act on 5‑HT1B/1D receptors. Rizatriptan generally has a faster onset of action and may be preferred for patients who need rapid relief, while sumatriptan has a longer history of use and a broader range of available formulations.

Maxalt tablets should be stored at ambient temperature, preferably below 25 °C. Keep the medication in its original container, protect it from moisture and direct sunlight, and ensure it is out of reach of children.

Maxalt is taken orally as a tablet with or without water. It is usually taken at the first sign of a migraine attack. Patients should follow the dosing instructions provided by their prescriber and avoid taking more than the recommended number of tablets within a 24‑hour period.

The most serious risks include chest discomfort or tightness that could indicate cardiac ischemia, severe allergic reactions such as rash or swelling, and serotonin syndrome when combined with other serotonergic drugs. Any of these symptoms require immediate medical attention.

Maxalt should be avoided in patients with uncontrolled hypertension, significant cardiovascular disease (including coronary artery disease, stroke, or peripheral vascular disease), a history of hemiplegic or basilar migraine, or those taking contraindicated medications such as ergot alkaloids or MAO inhibitors.